Literature DB >> 1373644

IL-4-induced expression of germline gamma 1 transcripts in B cells following cognate interactions with T helper cells.

M T Berton1, E S Vitetta.   

Abstract

T cell-dependent B cell activation and the induction of isotype switching require antigen and direct contact with helper T (Th) cells. During activation, B cells can switch from the expression of IgM to that of IgG, IgE or IgA, depending on the lymphokines secreted by the Th cell with which they interact. Studies of lipopolysaccharide (LPS)-activated B cells have suggested that lymphokines regulate isotype switching via a transcriptional mechanism that increases the accessibility of downstream CH genes to a switch recombinase(s). To assess the roles of T cell contact and lymphokines in isotype switching, we have examined the accessibility model for the regulation of isotype switching to IgG1 in the context of cognate interactions between Th cells and normal B cells. We demonstrate that Th2 cells that secrete IL-4 can induce expression of germline gamma 1 transcripts in B cells. The steady-state level of germline gamma 1 transcripts induced by Th2 cells is enhanced as compared with the level induced by IL-4 alone or Il-4 and LPS also alters the relative usage of the germline gamma 1 transcription initiation sites. Enhanced expression of germline gamma 1 transcripts requires direct contact between T and B cells suggesting a role for T cell contact-mediated signals in regulating the accessibility of switch regions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373644     DOI: 10.1093/intimm/4.3.387

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  2 in total

1.  Germ-line transcripts and class switching.

Authors:  J Farrant
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

2.  Immunoglobulin switch transcript production in vivo related to the site and time of antigen-specific B cell activation.

Authors:  K M Toellner; A Gulbranson-Judge; D R Taylor; D M Sze; I C MacLennan
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.